U-47700

U-47700 is a prohibited substance in Australia. The Poisons Standard lists it in Schedule 9 under its systematic name, 3,4-dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-methylbenzamide (CAS No. 82657-23-6). Schedule 9 covers substances which may be abused or misused and whose manufacture, possession, supply or use should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with the approval of Commonwealth and/or state or territory health authorities. Schedule 9 separately captures the wider chemical class of N,N-dialkylaminocyclohexyl alkyl benzamides except where a member is specified elsewhere in the schedules, and the Poisons Standard takes effect through the poisons and drugs legislation of each state and territory rather than applying of its own force.

U-47700 is listed by name in Annexe IA of Belgium's Royal Decree of 6 September 2017 regulating narcotic and psychotropic substances, the annex reserved for substances in Table I of the 1961 Single Convention. It was inserted there by the Royal Decree of 9 December 2019, in force since 16 January 2020, and the Federal Agency for Medicines and Health Products' consolidated Annexe IA valid from 29 March 2026 still names it. Listing makes it an offence to import, export, transport, manufacture, produce, hold, sell or offer for sale, supply, deliver or acquire the substance without a prior activities authorisation from the Minister, which is issued only for scientific or medical purposes. Control attaches to U-47700 itself and, where chemically possible, to its isomers, esters, ethers and salts; breaches carry the penalties of Article 2bis of the Law of 24 February 1921.

U-47700 is a controlled drug in Ireland, declared as such by the Government under section 2(2) of the Misuse of Drugs Act 1977. It is listed by name in Schedule 1 to the Misuse of Drugs Regulations 2017, the schedule reserved for substances with no accepted medicinal use, so it is not available on prescription and any dealing with it requires a licence from the Minister for Health. A designation order under section 13 of the Act makes its manufacture, production, preparation, sale, supply, distribution and possession unlawful except for research, forensic analysis, or use as an essential intermediate or starting material in an industrial manufacturing process. The controls extend to any stereoisomeric form, ester, ether or salt of the substance and to any preparation or product containing it.

U-47700 is listed as item 186 among the Group I-N narcotic drugs in Annex 2 to the Minister of Health's regulation of 17 August 2018 on the list of psychotropic substances, narcotic drugs and new psychoactive substances, identified by the chemical designation 3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide. The Group I-N listing also covers isomers, esters, ethers and salts of the substances it names where such forms are chemically possible and are not scheduled elsewhere. Possession of a narcotic drug contrary to the Act on Counteracting Drug Addiction of 29 July 2005 is punishable under Article 62 by up to three years' imprisonment, rising to between one and ten years where a significant quantity is involved. Later amendments to the regulation add further substances to Group I-N but leave the U-47700 entry unchanged.

U-47700 is a List B euphoriant substance in Denmark, appearing as entry 445 of annex 1 to the Executive Order on Euphoriant Substances under its exact chemical name 3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide, printed with the shorthand "U-4770". List B substances may be used in the country only for medical or scientific purposes, and import, export, sale, purchase, supply, receipt, manufacture, processing and possession are lawful only in accordance with the order's licensing and prescribing provisions. The control extends to the substance's salts and simple derivatives with euphoriant effect and to any preparation containing or made from it. U-47700 was inserted into List B on 15 June 2017, and breaches are punished under the Euphoriant Substances Act or, in aggravated circumstances, under section 191 of the Criminal Code.

S.O. 823(E) declares U-47700, identified as 3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide, and its salts and preparations to be manufactured drugs. The Act defines manufactured drugs as narcotic drugs, and section 8(c) prohibits producing, manufacturing, possessing, selling, purchasing, transporting, using, consuming, importing, exporting, or transhipping narcotic drugs except for medical or scientific purposes as provided by the Act, rules, orders, and any required licence, permit, or authorisation.

U-47700 is listed by name in List I of the Dutch Opium Act (Opiumwet), the schedule reserved for substances presenting unacceptable risk. It was added to that list by a royal decree of 9 April 2018, published in Staatsblad 2018, 110 and in force from 27 April 2018, implementing the March 2017 UN Commission on Narcotic Drugs scheduling decisions. Article 2 of the Opiumwet forbids importing or exporting, cultivating, preparing, processing, selling, delivering, supplying, transporting, possessing and manufacturing any List I substance. The listing names U-47700 itself in the "andere benamingen" column, with no separate entry limiting control to particular preparations or products.

U-47700 is a narcotic drug under Spain’s Ley 17/1967 because it is included in Schedule I of the 1961 Single Convention. The law places its production, manufacture, storage, transport, distribution, import, export, possession, use and consumption under State intervention and permits only authorized industrial, therapeutic, scientific and teaching uses. Operations contrary to the law are illicit trafficking; U-47700 is not one of the Schedule IV narcotics that article 2.2 calls prohibited articles outright.